China Nutrition Voacanga Africana Extract Raw Material CAS 1617-90-9 API Natural Pure 99% Vincamine Powder, Find details about China Vincamine, CAS 1617-90-9 from Nutrition Voacanga Africana Extract Raw Material CAS 1617-90-9 API Natural Pure 99% Vincamine Powder
{Product Name}: | Vincamine |
{Other Name}: | N/A |
{Test Method.}: | HPLC |
{Appearence.}: | White Powder |
{Specification}: | 99% |
{MOQ}: | 1kg |
Vincamine is a peripheral vasodilator that increases blood flow to the brain. Generic drugs containing vincamine exist in specific regions. Most common drug preparations are in the sustained release forms. Vincamine is a monoterpenoid indole alkaloid found in the leaves of Vinca minor, comprising about 25-65% of the indole alkaloids found in Vinca minor by weight. It can be synthesized from related alkaloids. Vincamine is often used as a nootropic agent to combat the effects of aging, or in conjunction with other nootropics (such as piracetam) for a variety of purposes.
Function of Nutrition Voacanga Africana Extract Raw Material CAS 1617-90-9 API Natural Pure 99% Vincamine Powder
1.Vincamine can be used for the treatment of psychological and behavioral disorders caused by aging.
2.It can also be used for acute cerebrovascular disease and traumatic brain injury syndrome treatment.
3.Ophthalmology aspects: for the treatment of ischemic retinal diseases.
4.Otology aspects: for the treatment of cochlea vestibular diseases.
Application of Nutrition Voacanga Africana Extract Raw Material CAS 1617-90-9 API Natural Pure 99% Vincamine Powder
Vincamine is used for the prevention and treatment of cerebrovascular insufficiencies and disorders.
Vinpocetine might improve blood flow to the brain, it is used for enhancing memory and preventing Alzheimer's disease and other conditions that harm learning, memory, and information processing skills as people age.
Vincamine dietary supplements are sold in the US as "brain nutrition" to support cerebral metabolism and cognitive function and to enhance memory and concentration.
Send us an inquiry